ChromaTan, InnaMed and Group K Diagnostics, three startups that are located at the Science Center’s Port incubator, are streamlining different aspects of health care.
ChromaTan, a biotech company that relocated from State College, PA, is working on a technology that will advance antibody therapies while mitigating the cost of products for manufacturing companies. They currently have a $2.5 million FDA contract that they are using to develop their research.
InnaMed has already developed one product, a kidney and cardiovascular test that improve heart failure management. They are currently developing a blood testing device that will allow patients to test their blood at home, making it easier for both patients and health care providers alike.
The third startup, Group K Diagnostics, is developing a low-cost technology that will serve as a diagnostic system via an app. Through the app, samples from patients can be tested in approximately 20 minutes, which cuts down time in sending bloodwork to labs.
All three of these startups are working out of the Science Center’s Port business incubator, which serves as a hub for emerging life sciences and technology companies.
“The Port connects its residents to Greater Philadelphia’s diverse and supportive innovation ecosystem,” stated the Science Center’s press release. “Over the last four years, Port residents have successfully raised more than $250 million in capital.”
The Port is one of over 65 incubators, accelerators and co-working spaces in Greater Philadelphia that enhance collaboration and spark innovation.